CDEK
← All organizations

Omrix Biopharmaceuticals, Inc.

For profitContributed to NME

Also known as: Omrix Biopharmaceuticals | OMRIX Biopharmaceuticals | Omrix Biopharmaceuticals Ltd

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Nov 1, 2004

First marketed drug

Mar 21, 2003

First NDA

Aug 28, 2007

Last known activity

Jul 1, 2010

Acquired by Johnson and Johnson on Jan 1, 2008

Timeline

1990s

  1. Jan 1, 1995

    Omrix Biopharmaceuticals, Inc.— Founded

2000s

  1. Mar 21, 2003

    thrombin (bovine)— NDA Secondary Org

  2. Aug 28, 2007

    thrombin (human coagulation factor iia)— NDA Organization

  3. Jan 1, 2008

    Johnson and Johnson— Acquired By

Drugs by trial phase (7 distinct, 10 trials)

Phase 2 (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (3)

Recent trials (11)

Details

Founded
Qiryat Ono, IL Jan 1, 1995
First NDA
Aug 28, 2007
Last known activity
Jul 1, 2010